Publications by authors named "Emily F N Yuki"

Claim this Profile
E
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with rheumatoid arthritis: a 12-month observational study.
Fanny Reyes-Neira, Barbara Bayeh, Karina Rossi Bonfiglioli, Nadia Emi Aikawa, Ana Paula Luppino Assad, Emily Figueiredo Neves Yuki, Andrea Yukie Shimabuco

Adv Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study.
Leonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, Sandra G Pasoto, Eduardo F Borba, Emily F N Yuki

J Clin Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations.
Guillermo J Pons-Estel, Odirlei Andre Monticielo, Edgard Torres Dos Reis Neto, Juan Manuel Mejia-Vilet, Ibrahim Al-Homood, Emily Figueiredo Neves Yuki

Lupus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of mycobacterial infections in a cohort of silicosis patients with autoimmune rheumatic diseases.
Rafael Futoshi Mizutani, Ubiratan Paula Santos, Roberta Karla Barbosa Sales, Emily Figueiredo Neves Yuki, Elisa Maria Siqueira Lombardi

J Bras Pneumol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
Edgard Torres Dos Reis-Neto, Luciana Parente Costa Seguro, Emília Inoue Sato, Eduardo Ferreira Borba, Evandro Mendes Klumb, Emily Figueiredo Neves Yuki

Adv Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromodulation with aerobic exercise reduces fatigue in systemic lupus erythematosus: a randomised, sham-controlled, double-blind study.
Vanessa P de Andrade, Alexandre M Dos Santos, Luciana P C Seguro, Emily F N Yuki, Michelle R U Lopes

Clin Exp Rheumatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healing of tumor-induced osteomalacia as assessed by high-resolution peripheral quantitative computed tomography is not similar across the skeleton in the first years following complete tumor excision.
Nilton Salles Rosa Neto, Rosa Maria Rodrigues Pereira, Emily Figueiredo Neves Yuki, Fernando Henrique Carlos de Souza, Liliam Takayama

Bone Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
Edgard Torres Dos Reis-Neto, Luciana Parente Costa Seguro, Emília Inoue Sato, Eduardo Ferreira Borba, Evandro Mendes Klumb, Emily Figueiredo Neves Yuki

Adv Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment.
Alexandre Wagner S de Souza, João Gabriel Dantas, Ana Carolina de Oliveira E Silva Montandon, Ana Luísa Calich, Andrea Rocha de Saboia Mont' Alverne, Emily Figueiredo Neves Yuki

Adv Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjögren syndrome.
Sandra Gofinet Pasoto, Eduardo Ferreira Borba, Francisco Fellipe Claudino Formiga, Tatiana do Nascimento Pedrosa, Nadia Emi Aikawa, Emily Figueiredo Neves Yuki

Clin Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition.
Clovis Artur Silva, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Sandra Gofinet Pasoto, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Samuel Katsuyuki Shinjo

Adv Rheumatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
Carla G S Saad, Matheus S R Silva, Perceval D Sampaio-Barros, Julio C B Moraes, Cláudia G Schainberg, Emily F N Yuki

Joint Bone Spine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, Carla G S Saad, Sandra G Pasoto, Emily F N Yuki

Rheumatology (Oxford)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Rosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, Lucas P Sales, Sandra G Pasoto, Emily F N Yuki

Clinics (Sao Paulo)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Clovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, Emily F N Yuki, Sandra G Pasoto

Nat Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.
Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, Alexandre M Dos Santos, Renata Miossi, Emily F N Yuki

Rheumatology (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Nádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, Carla Goncalves Schahin Saad, Emily Figueiredo Neves Yuki, Samuel Katsuyuki Shinjo

Ann Rheum Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Emily Figueiredo Neves Yuki

Ann Rheum Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis.
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Henrique Carriço da Silva, Emily Figueiredo Neves Yuki

Ann Rheum Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Lucas C Netto, Karim Y Ibrahim, Camila M Picone, Ana Paula P S Alves, Eliane V Aniceto, Emily F N Yuki

Lancet HIV· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus.
Emily F N Yuki, Eduardo F Borba, Sandra G Pasoto, Luciana P Seguro, Michelle Lopes

Arthritis Care Res (Hoboken)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases.
Bruno Gualano, Italo R Lemes, Rafael P Silva, Ana J Pinto, Bruna C Mazzolani, Emily F N Yuki

Brain Behav Immun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients.
Bruno Gualano, Carla G S Saad, Sofia M Sieczkowska, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Emily F N Yuki

J Appl Physiol (1985)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.
Nadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, Ana C Medeiros-Ribeiro, Emily F N Yuki

Lancet Rheumatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
Adriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba, Nadia Emi Aikawa, Sandra Gofinet Pasoto, Emily Figueiredo Neves Yuki, Samuel Katsuyuki Shinjo

PLoS Negl Trop Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis